Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders

Leukemia Research

Volumn 28, Issue 11, 2004, Pages 1145-1151

  Bock, Oliver ^a   Tessema, Mathewos ^a   Serinsöz, Ebru ^a   Wasielewski, Reinhard Von ^a   Büsche, Guntram ^a   Kreipe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chronic myeloproliferative disorders; essential thrombocythaemia; ET; idiopathic myelofibrosis; IGF 2; IMF; insulin like growth factor 2; Ph CMPD; Philadelphia chromosome negative chronic myeloproliferative disorders; polycythaemia vera; PV

Indexed keywords

SOMATOMEDIN B;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PATHOGENESIS; PHILADELPHIA 1 CHROMOSOME; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; THROMBOCYTHEMIA; TRANSLATION INITIATION;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CHRONIC DISEASE; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4544359606     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.03.009     Document Type: Article

References (28)

1. Tefferi A. The pathogenesis of chronic myeloproliferative diseases. Int. J. Hematol. 73:2001;170-176
2. Li C.Y. The role of morphology, cytochemistry, and immunohistochemistry in the diagnosis of chronic myeloproliferative diseases. Int. J. Hematol. 76(Suppl 2):2002;6-8
3. Kralovics R., Buser A.S., Teo S.S., Coers J., Tichelli A., Van Der Maas A.P., et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood. 102:2003;1869-1871
4. Moschos S.J., Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 63:2002;317-332
5. Mansky P.J., Liewehr D.J., Steinberg S.M., Chrousos G.P., Avila N.A., Long L., Bernstein D., Mackall C.L., Hawkins D.S., Helman L.J. Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels. J. Pediatr. Hematol. Oncol. 24:2002;440-446
6. LeRoith D., Werner H., Neuenschwander S., Kalebic T., Helman L.J. The role of the insulin-like growth factor-I receptor in cancer. Ann. N.Y. Acad. Sci. 66:1995;402-408
7. LeRoith D., Roberts C.T. Jr. The insulin-like growth factor system and cancer. Cancer Lett. 195:2003;127-137
8. Ransohoff D.F. Developing molecular biomarkers for cancer. Science. 299:2003;1679-1680
9. Paulsen M., Ferguson-Smith A.C. DNA methylation in genomic imprinting, development, and disease. J. Pathol. 195:2001;97-110
10. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science. 299:2003;1753-1755
11. Ravenel J.D., Broman K.W., Perlman E.J., Niemitz E.L., Jayawardena T.M., Bell D.W., et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl. Cancer Inst. 93:2001;1698-1703
12. Vu T.H., Chuyen N.V., Li T., Hoffman A.R. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res. 63:2003;1900-1905
13. Looijenga L.H., Verkerk A.J., De Groot N., Hochberg A.A., Oosterhuis J.W. H19 in normal development and neoplasia. Mol. Reprod. Dev. 46:1997;419-439
14. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor-suppressor activity of H19 RNA. Nature. 365:1993;764-767
15. Wilkin F., Paquette J., Ledru E., Hamelin C., Pollak M., Deal C.L., et al. H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels. Eur. J. Biochem. 267:2000;4020-4027
16. Nunez C., Bashein A.M., Brunet C.L., Hoyland J.A., Freemont A.J., Buckle A.M., et al. Expression of the imprinted tumor-suppressor gene H19 is tightly regulated during normal haematopoiesis and is reduced in haematopoietic precursors of patients with the myeloproliferative disease polycythaemia vera. J. Pathol. 190:2000;61-68
17. Bock O., Schlue J., Kreipe H. Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders. Leukemia. 17:2003;815-816
18. Bock O., Kreipe H., Lehmann U. One-step extraction of RNA from archival biopsies. Anal. Biochem. 295:2001;116-117
19. Bock O., Reising D., Kreipe H. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia. Diagn. Mol. Pathol. 12:2003;119-123
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:2001;402-408
21. Lehmann U., Bock O., Langer F., Kreipe H. Demonstration of light chain restricted clonal B-lymphoid infiltrates in archival bone marrow trephines by quantitative real-time polymerase chain reaction. Am. J. Pathol. 159:2001;2023-2029
22. Bock O., Lehmann U., Kreipe H. Quantitative intra-individual monitoring of BCR-ABL transcript levels in archival bone marrow trephines of patients with chronic myeloid leukemia. J. Mol. Diagn. 5:2003;54-60
23. von Wasielewski R., Mengel M., Wiese B., Rudiger T., Muller-Hermelink H.K., Kreipe H. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am. J. Clin. Pathol. 118:2002;675-682
24. Peters G., Gongoll S., Langner C., Mengel M., Piso P., Klempnauer J., et al. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. Virchows Arch. 443:2003;139-145
25. Ripoche M.A., Kress C., Poirier F., Dandolo L. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev. 11:1997;1596-1604
26. Duguay S.J., Jin Y., Stein J., Duguay A.N., Gardner P., Steiner D.F. Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J. Biol. Chem. 273:1998;18443-18451
27. Daughaday W.H., Emanuele M.A., Brooks M.H., Barbato A.L., Kapadia M., Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N. Engl. J. Med. 319:1988;1434-1440
28. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., Kinzler K.W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272